Localization of Mullerian inhibiting substance receptors in various human cancer cell lines

被引:0
|
作者
A. V. Rodina
N. V. Gukasova
V. A. Makarov
I. G. Kondrasheva
A. V. Khomyakova
G. A. Posypanova
O. N. Popova
E. Yu. Moskaleva
S. E. Severin
机构
[1] Moscow Research Institute of Medical Ecology,Moscow Department of Health Care
来源
Biochemistry (Moscow) | 2008年 / 73卷
关键词
human recombinant MIS; receptor localization; biological activity;
D O I
暂无
中图分类号
学科分类号
摘要
Recombinant human MIS (rhMIS) produced in transfected Chinese hamster ovary cells has been purified by immunoaffinity chromatography. In the absence of reducing agents, 140 kD homodimer and several oligomers with molecular masses from 280 to 1000 kD are present. Homodimer, tetramer, and higher-molecular-weight rhMIS fractions reduced survival of tumor cells. For these experiments, FITC-labeled rhMIS was used for binding and endocytosis studies by flow cytometry. Flow cytometry performed on MIS-sensitive cancer cell lines demonstrated specific binding of rhMIS. The majority of rhMIS receptors have cytosolic localization. Thus, the level of MIS receptors on the cell membrane was pro-portional to the content of MIS-binding proteins in the whole cell and defines a level of receptor-mediated endocytosis. The immunopurified rhMIS caused significant growth inhibition of ovarian and prostate adenocarcinoma and melanoma human cell lines in inhibition assays.
引用
收藏
相关论文
共 50 条
  • [1] Localization of Mullerian inhibiting substance receptors in various human cancer cell lines
    Rodina, A. V.
    Gukasova, N. V.
    Makarov, V. A.
    Kondrasheva, I. G.
    Khomyakova, A. V.
    Posypanova, G. A.
    Popova, O. N.
    Moskaleva, E. Yu.
    Severin, S. E.
    BIOCHEMISTRY-MOSCOW, 2008, 73 (07) : 797 - 805
  • [2] IDENTIFICATION OF MULLERIAN INHIBITING SUBSTANCE SPECIFIC BINDING IN HUMAN CELL-LINES
    MACLAUGHLIN, DT
    LEVIN, RK
    CATLIN, EA
    TAYLOR, LA
    PREFFER, FI
    DONAHOE, PK
    HORMONE AND METABOLIC RESEARCH, 1992, 24 (12) : 570 - 575
  • [3] Mullerian Inhibiting Substance inhibits invasion and migration of epithelial cancer cell lines
    Chang, Henry L.
    Pieretti-Vanmarcke, Rafael
    Nicolaou, Fotini
    Li, Xianlin
    Wei, Xiaolong
    MacLaughlin, David T.
    Donahoe, Patricia K.
    GYNECOLOGIC ONCOLOGY, 2011, 120 (01) : 128 - 134
  • [4] Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics
    Wei, Xiaolong
    Dombkowski, David
    Meirelles, Katia
    Pieretti-Vanmarcke, Rafael
    Szotek, Paul P.
    Chang, Henry L.
    Preffer, Frederic I.
    Mueller, Peter R.
    Teixeira, Jose
    MacLaughlin, David T.
    Donahoe, Patricia K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (44) : 18874 - 18879
  • [5] RECOMBINANT HUMAN MULLERIAN INHIBITING SUBSTANCE INHIBITS HUMAN OCULAR MELANOMA CELL-LINES INVITRO AND INVIVO
    PARRY, RL
    CHIN, T
    EPSTEIN, J
    HUDSON, PL
    POWELL, DM
    DONAHOE, PK
    CANCER RESEARCH, 1992, 52 (05) : 1182 - 1186
  • [6] MULLERIAN INHIBITING SUBSTANCE IN REPRODUCTION AND CANCER
    DONAHOE, PK
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 1992, 32 (02) : 168 - 172
  • [7] Anti-Proliferative and Apoptotic Activities of Mullerian Inhibiting Substance Combined with Calcitriol in Ovarian Cancer Cell Lines
    Jung, Yeon Soo
    Kim, Hee Jung
    Seo, Seok Kyo
    Choi, Young Sik
    Nam, Eun Ji
    Kim, Sunghoon
    Kim, Sang Wun
    Han, Hyuck Dong
    Kim, Jae Wook
    Kim, Young Tae
    YONSEI MEDICAL JOURNAL, 2016, 57 (01) : 33 - 40
  • [8] ANTIPROLIFERATIVE AND APOPTOTIC ACTIVITES OF MULLERIAN INHIBITING SUBSTANCE (MIS) COMBINED WITH CALCITRIOL IN OVARIAN CANCER CELL LINES.
    Jung, Y. S.
    Yim, G. W.
    Nam, E. J.
    Kim, S. H.
    Kim, S. W.
    Kim, Y. T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 305 - 305
  • [9] Mullerian Inhibiting Substance/Anti-Mullerian Hormone as a Cancer Treatment
    MacLaughlin, D. T.
    Pieretti-Vanmarcke, R.
    Chang, H. L.
    Preffer, F. I.
    Dombkowski, D.
    Szotek, P.
    Donahoe, P. K.
    PROCEEDINGS OF THE 13TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2008, : 91 - 99
  • [10] Human ovarian cancer, cell lines, and primary ascites cells express the human mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS
    Masiakos, PT
    MacLaughlin, DT
    Maheswaran, S
    Teixeira, J
    Fuller, AF
    Shah, PC
    Kehas, DJ
    Kenneally, MK
    Dombkowski, DM
    Ha, TU
    Preffer, FI
    Donahoe, PK
    CLINICAL CANCER RESEARCH, 1999, 5 (11) : 3488 - 3499